Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation
-
* Corresponding author: Jaro Wex jaro.wex@pharmarchitecture.com
- Equal contributors
1 PharmArchitecture Limited, Quatro House, Lyon Way, Camberley, Surrey, UK
2 Global Market Access Solutions, Ch. De Penguey 6B, St Prex, Switzerland
3 Department of Gynaecology and Obstetrics, University Hospital RWTH, Aachen, Germany
BMC Pregnancy and Childbirth 2009, 9:23 doi:10.1186/1471-2393-9-23
Published: 19 June 2009Additional files
Additional file 1:
STable 1 – Characteristics of studies included in the analyses. The data provides additional details on quality characteristics of studies included in the analyses.
Format: DOC Size: 32KB Download file
This file can be viewed with: Microsoft Word Viewer
